Journal of the American Heart Association

MARCH 8, 2024

Journal of the American Heart Association, Ahead of Print.

Quality of Life 40

Quality of Life Cardiac Arrest Hospital 40

HeartRhythm

MAY 29, 2024

Current guidelines recommend ICD implantation in individuals with symptomatic heart failure (HF) and reduced left ventricular ejection fraction (HFrEF) if they have been receiving optimal guideline directed medical therapy for at least 3-6 months and who are expected to have survival greater than one year with meaningful quality of life (1).

Defibrillator 40

Defibrillator Sudden Cardiac Death Quality of Life Exercise 40

American College of Cardiology

AUGUST 2, 2024

Iron deficiency (ID) is a common comorbidity among patients with heart failure (HF), and it is associated with reduced exercise tolerance and quality of life and serves as a marker of increased risk of hospitalizations and mortality.

Heart Failure 45

Heart Failure Quality of Life Exercise Hospital 45

The British Journal of Cardiology

NOVEMBER 29, 2023

In this study, we evaluated the change in left ventricular end-diastolic pressure (LVEDP) after primary percutaneous coronary intervention (PCI) and its impact on in-hospital outcomes and 30-day and three-month quality of life (SAQ-7), ejection fraction (EF), and major adverse cardiovascular events (MACE).

Quality of Life 52

Quality of Life Hospital Outcomes Angina 52

Becker's Hospital Review - Cardiology

JULY 9, 2024

per day can improve quality of life New study finds strict sodium restrictions may not benefit heart failure patients. Moderate salt intake of 3.0-4.5g

Heart Failure 69

Heart Failure Quality of Life 69

HeartRhythm

APRIL 30, 2024

Recurrent symptomatic supraventricular tachycardia (SVT) can significantly affect patients’ quality of life and is a common cause of hospitalizations in the US. In light of its outstanding risk/benefit profile, catheter ablation (CA) is nowadays the recommended therapy for SVT and can be performed during hospitalization.

Tachycardia 40

Tachycardia Ablation Quality of Life Hospital 40

DAIC

JULY 25, 2024

BioCardia previously confirmed alignment with the United States Food and Drug Administration (FDA) on the design of the 250-patient randomized, controlled trial and the minimum of 12-month primary composite endpoint of all cause death, reduction in major adverse cardiovascular events, and improvement in quality of life.

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

Frontiers in Cardiovascular Medicine

MARCH 17, 2024

The purpose of this report is to evaluate the potential burden on the National Health Service (NHS) and measure the health effects in terms of both quantity (life years) and quality-of-life aspects related to the reducer. Methods Two different economic evaluation models were developed as part of the analysis.

Angina 64

Angina Quality of Life Coronary Artery Disease Ischemia 64

HeartRhythm

MAY 2, 2024

Rhythm control with either medications or catheter ablation is an established strategy for symptomatic patients with atrial fibrillation (AF), by reducing arrhythmic burden and improving patient quality of life, as well as reducing the risk of heart failure hospitalization and mortality in select populations with concomitant AF and heart failure.

Atrial Fibrillation 45

Atrial Fibrillation Quality of Life Heart Failure Ablation 45

DAIC

APRIL 2, 2024

Data from the TRILUMINATE Pivotal trial demonstrated that patients who received TriClip experienced a marked improvement in the severity of their symptoms and quality of life, with benefits sustained at one year. are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105

European Journal of Heart Failure

NOVEMBER 29, 2023

The ESC HF III Registry collected data on baseline characteristics (hospital or clinic presentation), hospital course, diagnostic and therapeutic decisions in hospital and at the clinic visit; and on outcomes at 12-month follow-up.

Heart Failure 75

Heart Failure Preserved Ejection Fraction Quality of Life Biomarkers 75

Frontiers in Cardiovascular Medicine

JULY 31, 2024

It is a common cause of hospital admissions, significantly impacts quality of life, increases morbidity and decreases life expectancy. Atrial fibrillation (AF) represents the most common cardiac arrhythmia with significant morbidity and mortality implications.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Diet Arrhythmia 52

Open Heart

JANUARY 18, 2024

The primary endpoint assessed the key safety outcomes, the secondary endpoints were: the quality of life measured, the N-terminal pro-B-type natriuretic peptide (NT-proBNP) changes and 6 min walk test (6MWT). The improvement in quality of life and distance at the 6MWT in both groups was significant (p<0.001).

Coronary Artery Bypass Graft 94

Coronary Artery Bypass Graft Quality of Life Public Health Heart Failure 94

DAIC

JULY 29, 2024

The clearance allows CorVascular to immediately begin marketing and selling the devices to clinics, hospitals, and teaching institutions across the country, expanding access to diagnostic testing for a disease medical experts say is causing an amputation epidemic in the US. Existing customers have the option to trade-up.

Peripheral Arterial Disease 108

Peripheral Arterial Disease Certification Cerebrovascular Disease Quality of Life 108

DAIC

FEBRUARY 2, 2024

“Patients suffering with tricuspid regurgitation endure life-impairing symptoms and, until today, had no approved transcatheter treatment options,” said Susheel Kodali, MD , director, Structural Heart and Valve Center at Columbia University Irving Medical Center/New York-Presbyterian Hospital and TRISCEND II Study Principal Investigator.

Tricuspid 100

Tricuspid Quality of Life Bicuspid/Mitral Heart Failure 100

Frontiers in Cardiovascular Medicine

FEBRUARY 15, 2024

Methods A convenience sampling method was used to select study participants who were hospitalized for treatment between November 2022 and August 2023 at a tertiary hospital in Neijiang and met the inclusion and exclusion criteria.

Cancer 49

Cancer Thrombosis Quality of Life Nursing 49

DAIC

APRIL 5, 2024

Presentation title: QUALITY OF LIFE ASSESSMENT AT 30-DAYS FOLLOW-UP OF THE VALVOSOFT PIVOTAL STUDY ON SEVERE AORTIC VALVE STENOSE PATIENTS" (control number 16930) Time and date: April 8, 2024 - 9:32 a.m.–9:42 A summary of the poster session will be published on the Journal of the American College of Cardiology’s website. 9:42 a.m.

Aortic valve 52

Aortic valve Stenosis Aortic Quality of Life 52

Frontiers in Cardiovascular Medicine

APRIL 16, 2024

It worsens the quality of life of patients, leads to an increase in the mortality rate because of its association with a high risk of thromboembolic complications. However, most research in this area has focused on hospital patients. Atrial fibrillation (AF) is the most common heart rhythm disorder in clinical practice.

COVID-19 52

COVID-19 Atrial Fibrillation Quality of Life Outpatient 52

Open Heart

AUGUST 10, 2023

Individuals with HF and AF may have a reduced functional capacity and quality of life (QoL) which leads to hospital admission and burden on clinical services. Background Atrial fibrillation (AF) is common in individuals with heart failure (HF). Evidence supported the effect of exercise training in individuals with HF.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Atrial Fibrillation Heart Failure Quality of Life 52

Frontiers in Cardiovascular Medicine

JULY 14, 2024

ObjectiveThis study aimed to evaluate the integration of the Hospital-Community-Home (HCH) model with the Self-Mutual-Group (SMG) health management model for high-risk populations with cardiovascular disease in the Yuhua community of Shijiazhuang city.

Cardiovascular Disease 52

Cardiovascular Disease Quality of Life Exercise Angina 52

The British Journal of Cardiology

AUGUST 6, 2024

Individuals were screened following outpatient referral to Leeds Teaching Hospitals NHS Trust for symptomatic AF. Final follow-up at six months included clinical and weight data and a quality-of-life questionnaire. Sixty-four patients underwent randomisation. No significant difference in weight loss was seen between the groups.

Atrial Fibrillation 64

Atrial Fibrillation Obesity Quality of Life Outpatient 64

Open Heart

JULY 11, 2022

The aim of this study was to determine the impact of a short inpatient EMS intervention in severely deconditioned patients with HF on functional capacity and quality of life (QoL) over a follow-up period of 1 month. However, there is insufficient data on delayed effects of EMS starting early after decompensation.

Heart Failure 52

Heart Failure Hospital Quality of Life Exercise 52

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

This study aimed to assess quality-of-life (QOL) and healthcare utilization (HCU) benefits experienced by Q-FFICIENCY study participants. One-year Kaplan–Meier estimates of freedom from all-cause and cardiovascular hospitalization were 80.9% (95% confidence interval [CI], 74.8%–86.9%) 86.9%) and 88.8% (95% CI, 84.0%–93.7%),

Atrial Fibrillation 40

Atrial Fibrillation Ablation Quality of Life Hospital 40

European Journal of Heart Failure

DECEMBER 22, 2023

Abstract Right-sided heart failure and tricuspid regurgitation are common and strongly associated with poor quality of life and an increased risk of heart failure hospitalizations and death.

Heart Failure 75

Heart Failure Tricuspid Cardiovascular Interventions Quality of Life 75

DAIC

APRIL 16, 2024

Dr. JoAnn Lindenfeld of Vanderbilt University presented analysis showing that patients with Barostim + GDMT had sustained and significant improvements in quality-of-life scores (MLWHF and EQ-5D) and many subdomains of these scores (e.g., See more details at TCTMD. versus patients on GDMT alone.

Heart Failure 104

Heart Failure Quality of Life Transplant Heart Transplant 104

DAIC

MARCH 13, 2024

Treated patients also had reduced major adverse cardiac events and greatly improved quality of life. “We In the subgroup of patients targeted in the CardiAMP Heart Failure II Trial, results showed large absolute and relative risk reduction of heart death equivalents of the patients in the treated group. said Peter Altman , PhD.,

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

HeartRhythm

SEPTEMBER 20, 2023

Cardiac resynchronization therapy improves survival and quality of life and reduces HF hospitalizations in HF patients with LBBB.1 Conduction system pacing (CSP) is a promising new approach for delivering pacing therapy.1 Pacing therapy of LBBB-caused electrical dyssynchrony has a long and successful history.

Quality of Life 40

Quality of Life Research Heart Failure Hospital 40

Stroke Journal

FEBRUARY 1, 2024

The results were divided into qualitative and quantitative outcomes.Conclusions:11 effect domains were defined: functional, psychological, burden, social, general health and self-efficacy, family function, quality of life, health care utilization, preparedness, quality of care and relationship to technology.

Stroke 75

Stroke Strokes Quality of Life Nursing 75

DAIC

APRIL 25, 2024

“We are thrilled to have a new transcatheter valve option which allows patients to feel significantly better by alleviating symptoms such as shortness of breath and can help improve the patients’ quality of life.”

Tricuspid 111

Tricuspid Quality of Life Hospital Nursing 111

CardiacWire

FEBRUARY 14, 2024

Regardless , the FDA panelists largely supported quality of life as an important TR metric and were impressed with the TriClip’s safety profile, with one panelist explaining that “if we can help symptoms at a low cost in terms of risk, it makes a lot of sense.”

Tricuspid 59

Tricuspid Quality of Life Document Hospital 59

European Journal of Heart Failure

OCTOBER 31, 2023

This 2023 Cochrane review of 60 randomized trials in 8728 heart failure patients, confirms the benefits of participation in exercise-based cardiac rehabilitation (ExCR), including reduced risk of hospitalization and a clinically meaningful improvement in health-related quality of life. 1.01, MLWHF: −9.59, 95% CI −17.48

Cardiac Rehabilitation 40

Cardiac Rehabilitation Heart Failure Exercise Quality of Life 40

DAIC

JANUARY 4, 2024

a Structural Heart Disease Fellow at Henry Ford Hospital, is also optimistic that these findings will lead to helping more people. This minimally invasive technique pioneered at Henry Ford is a promising and safe treatment option for these patients to improve their cardiac symptoms and quality of life."

Heart Valves 119

Heart Valves Bicuspid/Mitral Open-Heart Surgery Stenosis 119

European Journal of Heart Failure

DECEMBER 13, 2023

Consistent effects were observed for heart failure, cardiovascular, and all-cause hospitalization, and deaths, and composites of these. In addition, dapagliflozin was safe and well-tolerated, irrespective of COPD status. The benefit of dapagliflozin on the primary outcome was consistent irrespective of COPD status (no COPD: HR 0.82 [95% CI 0.72–0.93];

Preserved Ejection Fraction 75

Preserved Ejection Fraction Heart Failure Pulmonary Quality of Life 75

Conquering CHD

JANUARY 16, 2024

But Chris was already pushing these boundaries as a dedicated athlete, and his doctor, Children’s Hospital Colorado Adult Congenital Heart Disease Director Joseph Kay, MD, supported him every step of the way. Chris’ desire to stay active has greatly improved his own quality of life, and it helps the d-TGA patients that come after him.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Quality of Life 52

DAIC

MAY 14, 2024

While invasive interventions can restore selected patients’ quality of life, pharmacologic therapies that are safe, well-tolerated and that reliably improve how patients feel and function remain an unmet need for patients with obstructive HCM. The late breaking research was presented by principal investigator Martin S.

Cardiomyopathy 126

Cardiomyopathy Exercise Chest Pain Quality of Life 126

DAIC

APRIL 9, 2024

Maron, MD “Our findings provide enthusiasm that a novel drug therapy with ninerafaxstat may provide nonobstructive HCM patients an opportunity to achieve a better quality of life by decreasing symptom burden and improving exercise capacity,” said Martin S. The safety and tolerability of the drug in this phase 2 trial was excellent.

Cardiomyopathy 52

Cardiomyopathy Quality of Life Preserved Ejection Fraction Chest Pain 52

European Journal of Heart Failure

OCTOBER 4, 2023

There was no significant treatment interaction by NCC number in quality-of-life improvement ( p  = 0.98) or the incidence of serious adverse events ( p  = 0.11). The treatment benefit of HIC versus UC on the primary endpoint did not differ significantly by each individual comorbidity.

Heart Failure 40

Heart Failure Hospital Quality of Life Pulmonary 40